Consumers drive SJW use but often do not disclose to their GPs, which is concerning due to issues about safety. Pharmacists could play an important role here. Improved education about SJW is required for both GPs and consumers, including the need for communication between them and their pharmacists. Lack of adoption of evidence-based therapy for depression should be explored further.
No takes yet. Share an insight, caveat, or question.
Forsdike et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: